LEDRU PHILIPPE 4
4 · Aptose Biosciences Inc. · Filed Apr 14, 2022
Insider Transaction Report
Form 4
LEDRU PHILIPPE
Chief Commercial Officer
Transactions
- Award
Employee Stock Option
2022-04-13+600,000→ 600,000 totalExercise: $1.25Exp: 2032-04-12→ Common Shares (600,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the shares vest on 4/13/2023; the remaining 50% vest as follows: 1/3 on 4/13/2024; 1/3 on 4/13/2025; and 1/3 on 4/13/2026.